SUPPORT Workbook for Urinary Incontinence
(SUPPORT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a home-based program designed to help women manage urinary incontinence (UI) and lower urinary tract symptoms (LUTS) through education, exercises, and behavioral changes. Participants will use a workbook to guide them through therapy exercises and receive support from a specially trained computer program. The trial aims to evaluate the effectiveness and ease of use of the SUPPORT program for different women at home. Women who feel bothered by their UI symptoms and are willing to try a non-medical treatment for 16 weeks may be a good fit for this trial. As an unphased trial, this study offers women the opportunity to explore a new, non-medical approach to managing their symptoms in the comfort of their homes.
Will I have to stop taking my current medications?
Yes, if you are currently taking medications for urinary incontinence or lower urinary tract symptoms, you cannot participate in this trial.
What prior data suggests that the SUPPORT program is safe for women with LUTS/UI?
Research shows that conservative treatments for urinary incontinence, such as the SUPPORT program, are generally safe. A study on a similar digital care program for women with urinary incontinence found it practical and safe. Programs that combine education, exercises, and behavior techniques are usually well-received. The SUPPORT program includes self-guided exercises and cognitive behavioral therapy, which are non-invasive and carry a low risk of side effects. Although specific safety data for the SUPPORT program itself is not available, these types of treatments typically maintain a good safety record. Participants can feel confident about the general safety of this approach.12345
Why are researchers excited about this trial?
Researchers are excited about the SUPPORT workbook for urinary incontinence because it combines traditional pelvic floor therapy techniques with innovative technology. Unlike standard treatments that typically involve in-person physical therapy sessions, the SUPPORT program provides patients with a workbook and access to a custom-trained GPT (a type of AI) that guides and supports them in performing exercises at home. This approach not only empowers patients with more flexibility and privacy in managing their condition but also incorporates empathetic communication techniques to enhance patient engagement. This hybrid method could revolutionize how patients receive care, making it more accessible and personalized.
What evidence suggests that the SUPPORT program is effective for urinary incontinence?
Research has shown that the SUPPORT program, which participants in this trial will receive, might help with urinary incontinence (UI). One study found that people experienced fewer urine leaks and improved quality of life even six months after treatment. Real-world evidence also supports the effectiveness and safety of digital health treatments for women with UI. Additionally, pelvic floor muscle exercises, included in the SUPPORT program, work equally well in groups and one-on-one sessions. These findings suggest that the SUPPORT program could effectively manage UI.46789
Who Is on the Research Team?
Kimberly Kenton, MD
Principal Investigator
University of Chicago
James Griffith, PhD
Principal Investigator
University of Chicago
Are You a Good Fit for This Trial?
This trial is for racially minoritized women experiencing urinary control symptoms or infections. Participants should be interested in a home-based, self-directed treatment program and willing to engage with the SUPPORT workbook and exercises over an 8-week period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in an 8-week, home-based SUPPORT program combining cognitive behavioral therapy, behavioral modifications, and home physical therapy exercises.
Follow-up
Participants are monitored for changes in urinary symptoms and other outcomes 8 and 16 weeks after SUPPORT program initiation.
Long-term Follow-up
Participants' urinary symptoms and program adherence are assessed 16 weeks after SUPPORT program initiation.
What Are the Treatments Tested in This Trial?
Interventions
- SUPPORT program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Northwestern University
Collaborator